132 related articles for article (PubMed ID: 11052928)
1. Circulating C-type natriuretic peptide is increased in orthotopic cardiac transplant recipients and associated with cardiac allograft vasculopathy.
Buckley MG; Jenkins GH; Mitchell AG; Yacoub MH; Singer DR
Clin Sci (Lond); 2000 Nov; 99(5):467-72. PubMed ID: 11052928
[TBL] [Abstract][Full Text] [Related]
2. Fluid homeostasis after heart transplantation: the role of cardiac denervation.
Braith RW; Mills RM; Wilcox CS; Convertino VA; Davis GL; Limacher MC; Wood CE
J Heart Lung Transplant; 1996 Sep; 15(9):872-80. PubMed ID: 8889982
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation.
Mehra MR; Uber PA; Potluri S; Ventura HO; Scott RL; Park MH
Am J Cardiol; 2004 Aug; 94(4):454-8. PubMed ID: 15325928
[TBL] [Abstract][Full Text] [Related]
4. Cardiac function in children post-orthotopic liver transplantation: echocardiographic parameters and biochemical markers of subclinical cardiovascular damage.
Shalev A; Nir A; Granot E
Pediatr Transplant; 2005 Dec; 9(6):718-22. PubMed ID: 16269041
[TBL] [Abstract][Full Text] [Related]
5. Transcoronary and pulmonary vascular dynamics of endothelin-1 in heart transplant recipients.
Sudhir K; DeMarco T; Kumar S; Maganti K; Amidon TM; de Groot CJ; Klinski C; Lau D; Keith F; Taylor RN
J Heart Lung Transplant; 1995; 14(2):230-5. PubMed ID: 7779840
[TBL] [Abstract][Full Text] [Related]
6. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation.
Haji SA; Starling RC; Avery RK; Mawhorter S; Tuzcu EM; Schoenhagen P; Cook DJ; Ratliff NB; McCarthy PM; Young JB; Yamani MH
J Heart Lung Transplant; 2004 Mar; 23(3):277-83. PubMed ID: 15019636
[TBL] [Abstract][Full Text] [Related]
7. Coronary flow reserve impairment predicts cardiac events in heart transplant patients with preserved left ventricular function.
Rodrigues AC; Frimm Cde C; Bacal F; Andreolli V; Tsutsui JM; Bocchi EA; Mathias W; Lage SG
Int J Cardiol; 2005 Aug; 103(2):201-6. PubMed ID: 16080981
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction.
Del Ry S; Giannessi D; Maltinti M; Prontera C; Iervasi A; Colotti C; Emdin M; L'Abbate A; Neglia D
Peptides; 2007 May; 28(5):1068-73. PubMed ID: 17428580
[TBL] [Abstract][Full Text] [Related]
9. Amino-terminal fragment of C-type natriuretic peptide precursor and C-type natriuretic peptide do not correlate in patients with Chagas disease: role for neutral endopeptidase.
Wang Y; Moreira Mda C; Heringer-Walther S; Schultheiss HP; Siems WE; Wessel N; Walther T
J Cardiovasc Pharmacol; 2010 Jan; 55(1):62-6. PubMed ID: 20090473
[TBL] [Abstract][Full Text] [Related]
10. Does circulating BNP normalize after heart transplantation in patients with normal hemodynamic and right and left heart functions?
Talha S; Di Marco P; Doutreleau S; Rouyer O; Piquard F; Geny B
Clin Transplant; 2008; 22(5):542-8. PubMed ID: 18394002
[TBL] [Abstract][Full Text] [Related]
11. C-type natriuretic peptide production by the human kidney is blunted in chronic heart failure.
Kalra PR; Clague JR; Coats AJ; Anker SD; Poole-Wilson PA; Struthers AD
Clin Sci (Lond); 2009 Oct; 118(1):71-7. PubMed ID: 19450232
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles and B-type natriuretic peptide elevation in heart transplantation: more than a hemodynamic marker.
Mehra MR; Uber PA; Walther D; Vesely M; Wohlgemuth JG; Prentice J; Tayama D; Billingham M
Circulation; 2006 Jul; 114(1 Suppl):I21-6. PubMed ID: 16820574
[TBL] [Abstract][Full Text] [Related]
13. Combined endothelial and myocardial protection by endothelin antagonism enhances transplant allograft preservation.
Fedak PW; Rao V; Verma S; Ramzy D; Tumiati L; Miriuka S; Boylen P; Weisel RD; Feindel CM
J Thorac Cardiovasc Surg; 2005 Feb; 129(2):407-15. PubMed ID: 15678053
[TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-C-type natriuretic peptide, but not C-type natriuretic peptide, is greatly elevated in the fetal circulation.
Prickett TC; Kaaja RJ; Nicholls MG; Espiner EA; Richards AM; Yandle TG
Clin Sci (Lond); 2004 May; 106(5):535-40. PubMed ID: 14717656
[TBL] [Abstract][Full Text] [Related]
15. Low HDL-C predicts the onset of transplant vasculopathy in pediatric cardiac recipients on pravastatin therapy.
Hedman M; Pahlman R; Sundvall J; Ehnholm C; Syvänne M; Jokinen E; Jauhiainen M; Holmberg C; Antikainen M
Pediatr Transplant; 2007 Aug; 11(5):481-90. PubMed ID: 17631015
[TBL] [Abstract][Full Text] [Related]
16. Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure.
Bentzen H; Pedersen RS; Nyvad O; Pedersen EB
Int J Cardiol; 2004 Feb; 93(2-3):121-30. PubMed ID: 14975537
[TBL] [Abstract][Full Text] [Related]
17. Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients.
Hama N; Itoh H; Shirakami G; Suga S; Komatsu Y; Yoshimasa T; Tanaka I; Mori K; Nakao K
Biochem Biophys Res Commun; 1994 Feb; 198(3):1177-82. PubMed ID: 8117275
[TBL] [Abstract][Full Text] [Related]
18. Endothelin participates in increased circulating atrial natriuretic peptide early after human heart transplantation.
Geny B; Piquard F; Follenius M; Thiranos JC; Charpentier A; Epailly E; Levy F; Kretz JG; Eisenmann B; Haberey P
J Heart Lung Transplant; 1998 Feb; 17(2):167-75. PubMed ID: 9513855
[TBL] [Abstract][Full Text] [Related]
19. Reduced incidence of hypertension after heterotopic cardiac transplantation compared with orthotopic cardiac transplantation: evidence that excision of the native heart contributes to post-transplant hypertension.
Taegtmeyer AB; Crook AM; Barton PJ; Banner NR
J Am Coll Cardiol; 2004 Sep; 44(6):1254-60. PubMed ID: 15364328
[TBL] [Abstract][Full Text] [Related]
20. Amino-terminal pro-C-type natriuretic peptide is associated with the presence, severity, and duration of vasculogenic erectile dysfunction.
Vlachopoulos C; Ioakeimidis N; Terentes-Printzios D; Rokkas K; Aznaouridis K; Baou K; Bratsas A; Fassoulakis C; Stefanadis C
Eur Urol; 2009 Sep; 56(3):552-8. PubMed ID: 19038490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
